2025
SJR Q2
JCR Q3 · 2
OA
9 matched articles
ESCI
Journal detail
Drugs - Real World Outcomes
- Country
- Switzerland · Western Europe
- Type
- journal
- ISSN
-
2198978821991154
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,662
- Quartile Q2
- H-Index 27
- Cites/doc 2,07
- Docs (3y) 186
- Cites (3y) 429
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2
- 5Y JIF 2,1
- JCI 0,56
WoS indexes
- ESCI
Subject classification
Categories (SJR)
- Pharmacology (medical) Q2
Areas
- Medicine
WoS categories
- Pharmacology & Pharmacy
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 0,662 | 2 | 2,1 | 0,56 | Q3 | 27 |
| 2024 | Q2 | Q3 | 0,673 | 1,9 | 1,9 | 0,53 | Q3 | 24 |
| 2023 | Q2 | Q3 | 0,564 | 1,9 | — | 0,58 | Q3 | 24 |
| 2022 | Q2 | — | 0,564 | 2 | — | 0,57 | Q3 | 24 |
| 2021 | Q2 | — | 0,532 | — | — | 0,66 | Q2 | 24 |
| 2020 | Q3 | — | 0,43 | — | — | — | — | 24 |
| 2019 | Q2 | — | 0,559 | — | — | — | — | 24 |
| 2017 | — | — | — | — | — | — | — | 24 |
| 2016 | — | — | — | — | — | — | — | 24 |
| 2015 | — | — | — | — | — | — | — | 24 |
| 2014 | — | — | — | — | — | — | — | 24 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PHARMACOLOGY & PHARMACY | ESCI | Q3 | Q3 | 249/356 |
| 2024 | PHARMACOLOGY & PHARMACY | ESCI | Q3 | Q3 | 238/352 |
| 2023 | PHARMACOLOGY & PHARMACY | ESCI | Q3 | Q3 | 231/354 |
| 2022 | PHARMACOLOGY & PHARMACY | ESCI | — | Q3 | — |
| 2021 | PHARMACOLOGY & PHARMACY | ESCI | — | Q2 | — |